Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    March 2019
  1. GERGES C, Gerges M, Lang IM
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  2. GRIGNOLA JC, Trujillo P, Domingo E
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    January 2019
  3. NEWNHAM M, South K, Bleda M, Auger WR, et al
    The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01805-2018.
    PubMed     Text format     Abstract available


    December 2018
  4. GRUNIG E, Eichstaedt C, Barbera JA, Benjamin N, et al
    ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00332-2018.
    PubMed     Text format     Abstract available


  5. EYRIES M, Montani D, Nadaud S, Girerd B, et al
    Widening the landscape of heritable pulmonary hypertension mutations in pediatric and adult cases.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01371-2018.
    PubMed     Text format     Abstract available


  6. GALIE N, McLaughlin VV, Rubin LJ, Simonneau G, et al
    An overview of the 6th World Symposium on Pulmonary Hypertension.
    Eur Respir J. 2018 Dec 14. pii: 13993003.02148-2018.
    PubMed     Text format    


  7. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    PubMed     Text format     Abstract available


  8. HOEPER MM, Benza RL, Corris P, de Perrot M, et al
    Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01906-2018.
    PubMed     Text format     Abstract available


  9. MCGOON MD, Ferrari P, Armstrong I, Denis M, et al
    The importance of patient perspectives in pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01919-2018.
    PubMed     Text format     Abstract available


  10. VONK NOORDEGRAAF A, Chin KM, Haddad F, Hassoun PM, et al
    Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01900-2018.
    PubMed     Text format     Abstract available


  11. VACHIERY JL, Tedford RJ, Rosenkranz S, Palazzini M, et al
    Pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01897-2018.
    PubMed     Text format     Abstract available


  12. FROST A, Badesch D, Gibbs JSR, Gopalan D, et al
    Diagnosis of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01904-2018.
    PubMed     Text format     Abstract available


  13. HUMBERT M, Guignabert C, Bonnet S, Dorfmuller P, et al
    Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01887-2018.
    PubMed     Text format     Abstract available


  14. KIM NH, Delcroix M, Jais X, Madani MM, et al
    Chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01915-2018.
    PubMed     Text format     Abstract available


  15. SIMONNEAU G, Montani D, Celermajer DS, Denton CP, et al
    Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01913-2018.
    PubMed     Text format     Abstract available


    November 2018
  16. KLOK FA, Barco S, Konstantinides SV, Dartevelle P, et al
    Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01687-2018.
    PubMed     Text format    


  17. SWIETLIK EM, Ruggiero A, Fletcher AJ, Taboada D, et al
    Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01787-2018.
    PubMed     Text format    


    October 2018
  18. DELCROIX M, Staehler G, Gall H, Grunig E, et al
    Risk assessment in medically treated Chronic Thromboembolic Pulmonary Hypertension patients.
    Eur Respir J. 2018 Oct 18. pii: 13993003.00248-2018.
    PubMed     Text format     Abstract available


  19. TURPIN M, Chantalat-Auger C, Parent F, Driss F, et al
    Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.
    Eur Respir J. 2018;52.
    PubMed     Text format     Abstract available


    August 2018
  20. GRUNE J, Kuebler WM
    Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension?
    Eur Respir J. 2018;52.
    PubMed     Text format    


    July 2018
  21. SOUMAGNE T, Guillien A, Chambellan A, Hua-Huy T, et al
    Global Lung Initiative equations in pulmonary hypertension screening in systemic sclerosis.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00528-2018.
    PubMed     Text format    


  22. QUADERY SR, Swift AJ, Billings C, Thompson A, et al
    The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00589-2018.
    PubMed     Text format     Abstract available


  23. BELLAYE PS, Yanagihara T, Granton E, Sato S, et al
    Macitentan reduces progression of TGF-beta1-induced pulmonary fibrosis and pulmonary hypertension.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01857-2017.
    PubMed     Text format    


    June 2018
  24. BADLAM JB, Austin ED
    Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  25. GUIGNABERT C, de Man F, Lombes M
    ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    May 2018
  26. KING CS, Brown AW, Shlobin OA, Weir N, et al
    Prevalence and Impact of WHO Group 3 Pulmonary Hypertension in Advanced Idiopathic Nonspecific Interstitial Pneumonia.
    Eur Respir J. 2018 May 17. pii: 13993003.00545-2018.
    PubMed     Text format    


  27. GUAZZI M
    Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  28. HOEPER MM, Boucly A, Sitbon O
    Age, risk and outcomes in idiopathic pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    April 2018
  29. HOEPER MM
    Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  30. CONDLIFFE R, Kovacs G
    Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    March 2018
  31. GERGES C, Gerges M, Fesler P, Maria Pistritto A, et al
    In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Mar 29. pii: 13993003.00067-2018.
    PubMed     Text format     Abstract available


  32. COGHLAN G, Wolf M, Distler O, Denton CP, et al
    Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
    Eur Respir J. 2018 Mar 21. pii: 13993003.01197-2017.
    PubMed     Text format     Abstract available


  33. BONNET S, Boucherat O
    The ROS controversy in hypoxic pulmonary hypertension revisited.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  34. OLSCHEWSKI H, Kovacs G, Herve P
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  35. LANGLEBEN D, Orfanos SE
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  36. BOUCLY A, Weatherald J, Humbert M, Sitbon O, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  37. HOEPER MM, Pittrow D, Opitz C, Gibbs JSR, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  38. DACCORD C, Letovanec I, Yerly P, Bloch J, et al
    First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    February 2018
  39. CARAVITA S, Dewachter C, Soranna D, Carolino D'Araujo S, et al
    Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.
    Eur Respir J. 2018 Feb 8. pii: 13993003.02427-2017.
    PubMed     Text format    


  40. PAK O, Scheibe S, Esfandiary A, Gierhardt M, et al
    Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01024-2017.
    PubMed     Text format     Abstract available


  41. HSU S, Tedford RJ
    Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  42. VACHIERY JL, Delcroix M, Al-Hiti H, Efficace M, et al
    Macitentan in pulmonary hypertension due to left ventricular dysfunction.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    January 2018
  43. TRAMPER J, Nossent EJ, Lely RJ, Krouwels FH, et al
    Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  44. COTTIN V, Price LC, Valenzuela C
    The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  45. KUMAR R, Graham B
    How does inflammation contribute to pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    October 2017
  46. BAUGHMAN RP, Shlobin OA
    Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  47. DEGANO B, Soumagne T, Delaye T, Berger P, et al
    Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  48. BOUCLY A, Cottin V, Nunes H, Jais X, et al
    Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  49. WEATHERALD J, Boucly A, Lau E, Godinas L, et al
    Are indexed values better for defining exercise pulmonary hypertension?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  50. MULLIN CJ, Hsu S, Amancherla K, Wand A, et al
    Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    August 2017
  51. HOEPER MM, Kramer T, Pan Z, Eichstaedt CA, et al
    Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  52. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    June 2017
  53. OLSSON KM, Wiedenroth CB, Kamp JC, Breithecker A, et al
    Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  54. JOUNEAU S, Ballerie A, Kerjouan M, Demant X, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  55. SANGES S, Prevotat A, Fertin M, Terriou L, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  56. KLOK FA, Hoeper MM
    Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    March 2017
  57. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  58. SCHERRER U, Verges S
    Sleep apnoea and pulmonary hypertension in high-altitude dwellers: more than an association?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  59. SIMONNEAU G, Hoeper MM
    Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  60. ENDE-VERHAAR YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, et al
    Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  61. NAKHLEH MK, Haick H, Humbert M, Cohen-Kaminsky S, et al
    Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    December 2016
  62. LATSHANG TD, Furian M, Aeschbacher SS, Ulrich S, et al
    Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.
    Eur Respir J. 2016 Dec 22. pii: 1601530. doi: 10.1183/13993003.01530-2016.
    PubMed     Text format     Abstract available


    November 2016
  63. RIOU M, Seferian A, Savale L, Chaumais MC, et al
    Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.
    Eur Respir J. 2016;48:1517-1519.
    PubMed     Text format    


    October 2016
  64. EID-LIDT G, Gaspar J, Sandoval J, Gonzalez-Pacheco H, et al
    Persistent pulmonary hypertension and right ventricular function after percutaneous mechanical thrombectomy in severe acute pulmonary embolism.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00910-2016. doi: 10.1183/13993003.00910-2016
    PubMed     Text format    


    September 2016

  65. "New potential diagnostic biomarkers for pulmonary hypertension." Svenja L. Tiede, Henning Gall, Oliver Dorr, Marina dos Santos Guilherme, Christian Troidl, Christoph Liebetrau, Sandra Voss, Robert Voswinckel, Ralph T. Schermuly, Werner Seeger, Friedr
    Eur Respir J. 2016;48:962.
    PubMed     Text format    


  66. LEVY M, Eyries M, Szezepanski I, Ladouceur M, et al
    Genetic analyses in a cohort of children with pulmonary hypertension.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00211-2016. doi: 10.1183/13993003.00211-2016.
    PubMed     Text format     Abstract available


    August 2016
  67. NAGARAJ C, Tang B, Nagy BM, Papp R, et al
    Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.
    Eur Respir J. 2016 Aug 18. pii: ERJ-01814-2015. doi: 10.1183/13993003.01814-2015
    PubMed     Text format     Abstract available


  68. GAMEN E, Seeger W, Pullamsetti SS
    The emerging role of epigenetics in pulmonary hypertension.
    Eur Respir J. 2016 Aug 4. pii: ERJ-01714-2015. doi: 10.1183/13993003.01714-2015.
    PubMed     Text format     Abstract available



  69. ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016;48:E68.
    PubMed     Text format    


    July 2016
  70. PARPALEIX A, Amsellem V, Houssaini A, Abid S, et al
    Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Eur Respir J. 2016 Jul 13. pii: ERJ-01448-2015. doi: 10.1183/13993003.01448-2015
    PubMed     Text format     Abstract available


    June 2016
  71. HASSOUN PM, Nathan SD
    Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.
    Eur Respir J. 2016;47:1615-7.
    PubMed     Text format    


    May 2016
  72. GERGES M, Gerges C, Lang IM
    How to define pulmonary hypertension due to left heart disease.
    Eur Respir J. 2016 May 12. pii: ERJ-00432-2016. doi: 10.1183/13993003.00432-2016
    PubMed     Text format    


    April 2016
  73. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


  74. NEDER JA, Ramos RP, Ota-Arakaki JS, Ferreira EM, et al
    Insights into ventilation-gas exchange coupling in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01948-2015. doi: 10.1183/13993003.01948-2015
    PubMed     Text format    


  75. MATHAI SC, Ghofrani HA, Mayer E, Pepke-Zaba J, et al
    Quality of life in patients with chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01626-2015. doi: 10.1183/13993003.01626-2015
    PubMed     Text format     Abstract available


  76. OLIVEIRA RK, Agarwal M, Tracy JA, Karin AL, et al
    Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
    Eur Respir J. 2016;47:1179-88.
    PubMed     Text format     Abstract available


    March 2016
  77. GODINAS L, Lau EM, Chemla D, Lador F, et al
    Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure.
    Eur Respir J. 2016 Mar 30. pii: ERJ-01678-2015. doi: 10.1183/13993003.01678-2015
    PubMed     Text format    


  78. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


    February 2016
  79. LAHM T
    Sex differences in pulmonary hypertension: are we cleaning up the mess?
    Eur Respir J. 2016;47:390-3.
    PubMed     Text format    


  80. TOSHNER M
    Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
    Eur Respir J. 2016;47:388-9.
    PubMed     Text format    


  81. MALENFANT S, Perros F
    beta-blockers in pulmonary arterial hypertension: generation might matter.
    Eur Respir J. 2016;47:682-4.
    PubMed     Text format    


  82. PRICE LC, Wort SJ
    Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.
    Eur Respir J. 2016;47:690-1.
    PubMed     Text format    


  83. MERAD M, Savale L, Antoun S, Vincent F, et al
    Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
    Eur Respir J. 2016;47:688-90.
    PubMed     Text format    


  84. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  85. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


    January 2016
  86. KOVACS G, Avian A, Olschewski H
    Proposed new definition of exercise pulmonary hypertension decreases false positive cases.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01394-2015. doi: 10.1183/13993003.01394-2015.
    PubMed     Text format    


  87. QUILOT FM, Georges M, Favrolt N, Beltramo G, et al
    Pulmonary hypertension associated with ponatinib therapy.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01110-2015. doi: 10.1183/13993003.01110-2015.
    PubMed     Text format    


  88. SOMMER N, Strielkov I, Pak O, Weissmann N, et al
    Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
    Eur Respir J. 2016;47:288-303.
    PubMed     Text format     Abstract available


    December 2015
  89. SABOOR F, Reckmann AN, Tomczyk CU, Peters DM, et al
    Nestin-expressing vascular wall cells drive development of pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00574-2015. doi: 10.1183/13993003.00574-2015
    PubMed     Text format     Abstract available


  90. GIRERD B, Montani D, Jais X, Eyries M, et al
    Genetic counselling in a national referral centre for pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00717-2015. doi: 10.1183/13993003.00717-2015
    PubMed     Text format     Abstract available



  91. "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)."
    Eur Respir J. 2015;46:1855-6.
    PubMed     Text format    


  92. SAVALE L, Chaumais MC, Sitbon O, Humbert M, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1851-3.
    PubMed     Text format    


  93. PRELLA M, Yerly P, Nicod LP, Aubert JD, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1849-51.
    PubMed     Text format    


    November 2015
  94. BARBERA JA, Blanco I
    Gaining insights into pulmonary hypertension in respiratory diseases.
    Eur Respir J. 2015;46:1247-50.
    PubMed     Text format    


    October 2015
  95. HUITEMA MP, Spee M, Vorselaars VM, Boerman S, et al
    Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Eur Respir J. 2015 Oct 22. pii: ERJ-01319-2015. doi: 10.1183/13993003.01319-2015
    PubMed     Text format    



  96. ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension.
    Eur Respir J. 2015;46:E58.
    PubMed     Text format    


  97. LAU EM, Tamura Y, McGoon MD, Sitbon O, et al
    The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress.
    Eur Respir J. 2015;46:879-82.
    PubMed     Text format    


    June 2015
  98. MANDERS E, Ruiter G, Bogaard HJ, Stienen GJ, et al
    Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension.
    Eur Respir J. 2015;45:1737-40.
    PubMed     Text format    


  99. ROBERTSON HT
    Dead space: the physiology of wasted ventilation.
    Eur Respir J. 2015;45:1704-16.
    PubMed     Text format     Abstract available


    April 2015
  100. HUERTAS A, Tu L, Thuillet R, Le Hiress M, et al
    Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Eur Respir J. 2015;45:1066-80.
    PubMed     Text format     Abstract available


    March 2015
  101. HOUSTON BA, Tedford RJ
    Stressing the stepchild: assessing right ventricular contractile reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:604-7.
    PubMed     Text format    


  102. SHARMA T, Lau EM, Choudhary P, Torzillo PJ, et al
    Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:700-8.
    PubMed     Text format     Abstract available


    January 2015
  103. COURAND PY, Pina Jomir G, Khouatra C, Scheiber C, et al
    Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:139-49.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: